Desoximetasone

Spezifikationen

382-67-2CAS-Nummer

206-845-3EG-Nummer

(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-oneIUPAC-Name

C22H29FO4Chemische Formel

376.5 g/molMolekulargewicht

desoximetasone; 382-67-2; Topicort; Desoxymethasone; Desoximetasona; Desoximetasonum; Topicort LP; Desossimetasone; HOE-304; HOE 304; R-2113; A-41-304; DTXSID3045647; (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one; 4E07GXB7AU; R 2113; J83.644C; CHEBI:691037; A-41304; NSC-759189; 9alpha-fluoro-16alpha-methyl-Delta(1)-corticosterone; DTXCID1025647; A 41304; (11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione; 9-Fluoro-11-beta,21-dihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione; 17 Desoxymethasone; 17-Desoxymethasone; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-, (11beta,16alpha)-; Topsilon; Stiedex lpn; Stiedex lp; Deoxydexamethasone; (1R,2S,10S,11S,13R,14S,15S,17S)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo(8.7.0.0^(2,7).0^(11,15))heptadeca-3,6-dien-5-one; (1R,2S,10S,11S,13R,14S,15S,17S)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one; (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta(a)phenanthren-3-one; RefChem:54952; D07AC03; D07XC02; A41304; 206-845-3; NSC10482; Desoxymetasone; 17-Deoxydexamethasone; Deoxymethasone; 9-Fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione; MFCD00083301; Esperson; MLS000028654; MLS001076073; (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one; Dexamethasone EP Impurity F; 17-Deoxymethansone; 17-Desoximethasone; 140218-14-0; NCGC00023648-03; SMR000058856; Flubason; Stiedex; Ibaril; A 41-304; Topicort (TN); CAS-382-67-2; Desossimetasone [DCIT]; Desoximetasone (USP/INN); UNII-4E07GXB7AU; Desoximetasonum [INN-Latin]; Desoximetasona [INN-Spanish]; EINECS 206-845-3; Desoximetasone [USAN:USP:INN:BAN]; BRN 2228097; 21-Desoxybetamethasone; Opera_ID_52; Dexamethasone Impurity F; Desoximetasone (Standard); DESOXIMETASONE [MI]; SCHEMBL4214; CHEMBL1766; DESOXIMETASONE [INN]; DESOXIMETASONE [JAN]; DESOXIMETASONE [USAN]; MLS001424230; DESOXIMETASONE [VANDF]; DESOXIMETASONE [MART.]; GTPL7067; orb1302747; orb3025702; DESOXIMETASONE [USP-RS]; DESOXIMETASONE [WHO-DD]; MSK2288; GLXC-20131; HMS2052C15; HMS2236H07; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-, (11.beta.,16.alpha.)-; DESOXIMETASONE [ORANGE BOOK]; Tox21_110889; BDBM50103622; DESOXIMETASONE [USP IMPURITY]; EBC-26851; HY-17570R; MSK2288-100A; s5685; DESOXIMETASONE [USP MONOGRAPH]; AKOS030254657; Tox21_110889_1; CCG-101120; DB00547; FF21375; NC00370; NSC 759189; NCGC00023648-04; (1S,2R,3aS,3bS,9aS,9bR,10S,11aS)-9b-fluoro-10-hydroxy-1-(2-hydroxyacetyl)-2,9a,11a-trimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one; AS-15787; HY-17570; SY075381; Desoximetasone; Dexamethasone EP Impurity F; D5515; NS00008529; T4572; DEXAMETHASONE IMPURITY F [EP IMPURITY]; D03697; T72402; Desoximetasone Solution in Acetonitrile, 100ug/mL; EN300-19737593; F787595; Q385370; 9-Fluoro-11b,21-dihydroxy-16a-methylpregna-1,4-diene-3,20-dione; 9-Fluoro-11|A,21-dihydroxy-16|A-methylpregna-1,4-diene-3,20-dione; 9alpha-fluoro-11beta,21-dihydroxy-16alpha-methyl-1.4-pregnadiene-3,20-dioneSynonyme